Healthcare / BiotechnologyNasdaqCM
$0.83
-0.04 (-4.60%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-27.9M · quality 29.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
11/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$157M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-140.9%
↓Gross Margin
73.3%
↑Debt/Equity
9.81
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-18.0%
FCF / Net income
1.38x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $154.9M · net income $-20.2M · FCF $-27.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $154.9M | $154.9M | $144.3M | $127.0M | $107.7M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | $-20.2M | $-20.2M | $-13.6M | $-110.6M | $-182.0M | $-220.7M | $-227.3M | $-204.7M | $-178.8M | $-197.5M | $-173.1M | $-97.6M | $-76.4M | $-55.3M | $-23.3M | $-11.8M | $-7.3M | $-10.0M |
| EBITDA | $-8.3M | $-8.3M | $-5.1M | $-103.8M | $-176.7M | $-214.8M | $-225.3M | $-208.7M | $-182.4M | $-193.0M | $-169.8M | $-96.2M | $-74.0M | $-54.1M | $-23.6M | $-10.9M | $-9.7M | $-9.9M |
| EPS | -0.12 | -0.12 | -0.09 | -0.80 | -1.67 | -2.24 | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross Margin | 73.3% | 73.3% | 73.2% | 48.8% | 49.0% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | -1.6% | -1.6% | -8.0% | -87.1% | -162.2% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Margin | -13.0% | -13.0% | -9.4% | -87.0% | -169.1% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 9.81 | 9.81 | -5.28 | -5.29 | 11.60 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current Ratio | 2.53 | 2.53 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $-27.9M | $-27.9M | $-24.2M | $-60.3M | $-148.7M | $-206.4M | $-191.6M | $-131.7M | $-201.0M | $-172.9M | $-137.2M | $-79.6M | $-61.7M | $-42.4M | $-18.0M | $-8.2M | $-5.6M | $-11.0M |
| Returns | ||||||||||||||||||
| ROE | -140.9% | -140.9% | 40.4% | 325.4% | -1341.2% | -284.5% | -96.1% | -50.7% | -48.3% | -150.6% | 814.8% | -82.6% | -121.1% | -80.2% | -45.1% | -75.0% | -558.2% | -147.6% |
| Valuation | ||||||||||||||||||
| P/B | 9.62 | 9.62 | — | — | 20.24 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | 7.4% | 7.4% | 13.6% | 18.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS Growth | -33.3% | -33.3% | 88.8% | 52.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-55.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.09 → -0.12
Residual
-55.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.